Inhibition of Microglial NLRP3 with MCC950 Attenuates Microglial Morphology and NLRP3/Caspase-1/IL-1β Signaling In Stress-induced Mice

被引：0
|
作者：
Qing Liu
Man-Man Zhang
Min-Xia Guo
Qiu-Ping Zhang
Na-Zhi Li
Jie Cheng
Shi-Le Wang
Guang-Hui Xu
Cheng-Fu Li
Ji-Xiao Zhu
Li-Tao Yi
机构：
[1] Huaqiao University,Department of Chemical and Pharmaceutical Engineering, College of Chemical Engineering
[2] Jiangxi University of Chinese Medicine,Research Center of Natural Resources of Chinese Medicinal Materials and Ethnic Medicine
[3] Xiamen Hospital of Traditional Chinese Medicine,Institute of Pharmaceutical Engineering
[4] Xiamen Medicine Research Institute,Fujian Provincial Key Laboratory of Biochemical Technology
[5] Huaqiao University,undefined
[6] Huaqiao University,undefined
来源：
Journal of Neuroimmune Pharmacology | 2022年 / 17卷
关键词：
NLRP3; Depression; Microglia; IL-1β; Neuroinflammation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：503 / 514
页数：11
相关论文
共 50 条
  • [1] Inhibition of Microglial NLRP3 with MCC950 Attenuates Microglial Morphology and NLRP3/Caspase-1/IL-1β Signaling In Stress-induced Mice
    Liu, Qing
    Zhang, Man-Man
    Guo, Min-Xia
    Zhang, Qiu-Ping
    Li, Na-Zhi
    Cheng, Jie
    Wang, Shi-Le
    Xu, Guang-Hui
    Li, Cheng-Fu
    Zhu, Ji-Xiao
    Yi, Li-Tao
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2022, 17 (3-4) : 503 - 514
  • [2] Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review
    Wu, Danbin
    Chen, Yefei
    Sun, Yingxin
    Gao, Qing
    Li, Huhu
    Yang, Zhengfei
    Wang, Yangxue
    Jiang, Xijuan
    Yu, Bin
    INFLAMMATION, 2020, 43 (01) : 17 - 23
  • [3] Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review
    Danbin Wu
    Yefei Chen
    Yingxin Sun
    Qing Gao
    Huhu Li
    Zhengfei Yang
    Yangxue Wang
    Xijuan Jiang
    Bin Yu
    Inflammation, 2020, 43 : 17 - 23
  • [4] Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death
    Matsuoka, Taisuke
    Yoshimatsu, Gumpei
    Sakata, Naoaki
    Kawakami, Ryo
    Tanaka, Tomoko
    Yamada, Teppei
    Yoshida, Yoichiro
    Hasegawa, Suguru
    Kodama, Shohta
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [5] MCC950, a NLRP3 inhibitor, ameliorates lipopolysaccharide-induced lung inflammation in mice
    Wang, Lu
    Lei, Wu
    Zhang, Shuijuan
    Yao, Li
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 30
  • [6] Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death
    Taisuke Matsuoka
    Gumpei Yoshimatsu
    Naoaki Sakata
    Ryo Kawakami
    Tomoko Tanaka
    Teppei Yamada
    Yoichiro Yoshida
    Suguru Hasegawa
    Shohta Kodama
    Scientific Reports, 10
  • [7] The NLRP3/ASC/Caspase-1 axis regulates IL-1ß processing in neutrophils
    Mankan, Arun K.
    Dau, Therese
    Jenne, Dieter
    Hornung, Veit
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 42 (03) : 710 - 715
  • [8] MicroRNA-24 attenuates diabetic vascular remodeling by suppressing the NLRP3/caspase-1/IL-1β signaling pathway
    Fan, Zhixing
    Yang, Jian
    Yang, Chaojun
    Zhang, Jing
    Cai, Wanying
    Huang, Congxin
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 45 (05) : 1534 - 1542
  • [9] Inhibition of the NLRP3 Inflammasome by MCC950 Accelerates Renal Injury in Diabetes Model
    Ostergaard, Jakob A.
    Jha, Jay C.
    Sharma, Arpeeta
    Dai, Aozhi
    Cooper, Mark E.
    de Haan, Judy B.
    Jandeleit-Dahm, Karin
    DIABETES, 2020, 69
  • [10] The NLRP3 inhibitor Mcc950 attenuates acute allograft damage in rat kidney transplants
    Zou, Xun-feng
    Gu, Jian-hua
    Duan, Ji-hui
    Hu, Zhan-dong
    Cui, Zi-lin
    TRANSPLANT IMMUNOLOGY, 2020, 61
12345